... citation purposes)
Vol 12 No 1
Research
Predictors of outcome in myxoedema coma: a study from a tertiary
care centre
Pinaki Dutta
1
, Anil Bhansali
1
, Shriq Rashid Masoodi
1
, Sanjay Bhadada
1
, ... were assessed by GCS and APACHE
II and SOFA scores. The SOFA score was calculated at
admission and every 2 days until discharge or death. The last-
day SOFA score was calcul...
... S, Bhadada S, Sharma N, Rajput R:
Predictors of outcome in myxoedema coma: a study from a
tertiary care centre. Crit Care 2008, 12:R1.
2. Nicoloff JT: Thyroid storm and myxedema coma. Med Clin
North ... fatal outcome. Acta Endocrinol
(Copenh) 1985, 108:65-71.
9. Yamamoto T, Fukuyama J, Fujiyoshi A: Factors associated with
mortality of myxedema coma: report of e...
... transcripts at baseline and were significantly elevated
(64-fold) following infection.
EZ4U assaying for syncytin mediated cytotoxicity
The transcripts encoding syncytin, found to be transacti-
vated in ... additional actions
of viral proteins or cellular responses to viral load remains
undetermined.
Qualitative analysis of HERV-W env and gag expression
We observed variations in Tm&ap...
... In a recent issue of Critical Care, Tabah and colleagues
[1] describe the quality of life after intensive care unit
(ICU) discharge in octogenarians. e quality is not
signifi cantly decreased ... better care but from better selection. Avoidance of
unnecessary suff ering and providing a good death can
also mean tremendous improvement in the care of
critically i...
... methodological issue,
cases in our study likely fall at the severe end of the DSH
spectrum. Whilst hospital admissions data was of high
quality, the hospital emergency data was inadequate to
allow analysis ... contains detailed perinatal
records from 1980 onwards. Hence only basic perinatal
data for WACHS children born before 1980 were available
for this analysis. Also, some childre...
... ratio adjusted for age, sex and
disease duration. ANA, antinuclear antibody; MTX, methotrexate.
Table 1
Demographic characteristics of the patients, ANA status at baseline and characteristics of ... Concerning DMARDs other than
methotrexate, use of sulphasalazine, of azathioprine and of all
other DMARDs as a group were not associated with infusion
reactions.
The association betwe...
... Euro-
pean Working Party on Systemic Lupus Erythematosus: Morbidity
and mortality in systemic lupus erythematosus during a 10-
year period. A comparison of early and late manifestations in
a cohort of ... J, Sebastiani GD, Gil A, Lavilla P,
Mej a JC, Aydintug AO, Chwalinska-Sadowska H, de Ramón E,
Fernández-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F,
Caro N, Alba P,...
... Research, Sydney, Australia, University of New South Wales, Sydney, Australia
Email: Simone E Langford* - simone.langford@med.monash.edu.au; Jintanat Ananworanich - jintanat .a@ searchthailand.org;
David ... found in East Africa
and Subtype CRF_01 AE is seen mainly in Thailand. Cau-
casians are predominantly infected by subtype B, seen in
12% of the global HIV infected population [...
... double-blind trial
comparing combinations of nevirapine, didanosine, and zidovudine for
HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada
and Australia Study. JAMA 1998, 279:930-7.
16. ... Grant E, Logie D, Masura M, Gorman D, Murray SA: Factors facilitating and
challenging access and adherence to antiretroviral therapy in a
township in the Zambian Copper belt:...